Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $123.83 USD
Updated Oct 30 4:00pm
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- EXAS has a market capitalization of $18,627,008,254 -- more than approximately 90.3% of US stocks.
- Over the past twelve months, EXAS has reported earnings growth of 179.92%, putting it ahead of 92.65% of US stocks in our set.
- Revenue growth over the past 12 months for Exact Sciences Corp comes in at 82.48%, a number that bests 93.59% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Exact Sciences Corp, a group of peers worth examining would be HZNP, NICE, CHKP, NDAQ, and HOLX.
- EXAS's SEC filings can be seen here. And to visit Exact Sciences Corp's official web site, go to www.exactsciences.com.
EXAS Stock Price Chart Interactive Chart >
EXAS Price/Volume Stats
| Current price | $123.83 | 52-week high | $141.90 |
| Prev. close | $120.50 | 52-week low | $35.25 |
| Day low | $118.41 | Volume | 2,103,400 |
| Day high | $123.84 | Avg. volume | 2,049,616 |
| 50-day MA | $92.89 | Dividend yield | N/A |
| 200-day MA | $84.68 | Market Cap | 18.63B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Loading social stream, please wait...